Mkts

BioNexus Gene Lab Corp

NASDAQ: BGLC
$0.68+0.00 (+0.00%)
As of Nov 20, 3:58 PM ET

Key statistics

Day range
0.680.73
52-week range
0.624.97
Today
Open0.68
Previous close0.68
Volume40.8K
Valuation
Market cap1.99M
P/E ratio—
EPS (TTM)-1.25
Income & risk
Dividend / yield—
Beta1.97
Avg volume9.9K
Discussion

BGLC News

Stories mentioning BGLC from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue23.00484.002,5442,2602,1372,5242,6301,975
Cost of Goods Sold24.00488.002,1661,8921,7942,2142,3041,686
Gross Profit(1.00)(4.00)378.00368.00343.00309.00327.00289.00
Operating Expenses
Research & Development14.0011.0015.0013.0012.0019.0010.008.00
Sales General & Admin
Total Operating Expenses597.001,0521,1881,1891,0532,6922,130760.00
Operating Income (Loss)(540.00)(1,033)(703.00)(611.00)(618.00)(416.00)(1,338)259.00
Interest Income
Interest Expense6.00
Other Expense58.0024.00108.00209.0091.00674.00466.00730.00
Pretax Income(544.00)(1,037)(709.00)(616.00)(623.00)(422.00)(1,344)255.00
Tax Provision0.000.000.000.000.00(41.00)2.0056.00
Net Income (Loss)(544.00)(1,037)(709.00)(616.00)(623.00)(348.00)(1,345)199.00
Earnings Per Share (Basic)
Earnings Per Share (Diluted)(0.23)(0.40)(0.34)(0.35)(0.02)(0.75)0.11
Weighted Average Shares Outstanding (Basic)
Weighted Average Shares Outstanding (Diluted)2,4171,7971,7971,79717,8181,7971,767

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BGLC

BioNexus Gene Lab Corp (NASDAQ: BGLC) is a stock listed on the Nasdaq Stock Market under the ticker symbol BGLC. It last traded at $0.6800 (Nov 20, 2026, 3:58 PM ET), unchanged on the day. That gives BioNexus Gene Lab a market capitalisation of $2.0M.

Over the past 52 weeks BGLC has traded between $0.6200 and $4.97.

Revenue for the quarter ended Mar 31, 2026 was $23.0K; a net loss of $544.0K. Revenue was down 98.9% from $2.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$23.0K-$544.0K-2365.2%
Dec 31, 2025$484.0K-$1.0M-214.3%
Sep 30, 2025$2.5M-$709.0K-27.9%
Jun 30, 2025$2.3M-$616.0K-27.3%

From BioNexus Gene Lab’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…